Literature DB >> 28159809

Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.

Kathryn M Spitler1, Jessica M Ponce1, Gavin Y Oudit2, Duane D Hall1, Chad E Grueter3.   

Abstract

The mediator complex, a multisubunit nuclear complex, plays an integral role in regulating gene expression by acting as a bridge between transcription factors and RNA polymerase II. Genetic deletion of mediator subunit 1 (Med1) results in embryonic lethality, due in large part to impaired cardiac development. We first established that Med1 is dynamically expressed in cardiac development and disease, with marked upregulation of Med1 in both human and murine failing hearts. To determine if Med1 deficiency protects against cardiac stress, we generated two cardiac-specific Med1 knockout mouse models in which Med1 is conditionally deleted (Med1cKO mice) or inducibly deleted in adult mice (Med1cKO-MCM mice). In both models, cardiac deletion of Med1 resulted in early lethality accompanied by pronounced changes in cardiac function, including left ventricular dilation, decreased ejection fraction, and pathological structural remodeling. We next defined how Med1 deficiency alters the cardiac transcriptional profile using RNA-sequencing analysis. Med1cKO mice demonstrated significant dysregulation of genes related to cardiac metabolism, in particular genes that are coordinated by the transcription factors Pgc1α, Pparα, and Errα. Consistent with the roles of these transcription factors in regulation of mitochondrial genes, we observed significant alterations in mitochondrial size, mitochondrial gene expression, complex activity, and electron transport chain expression under Med1 deficiency. Taken together, these data identify Med1 as an important regulator of vital cardiac gene expression and maintenance of normal heart function.NEW & NOTEWORTHY Disruption of transcriptional gene expression is a hallmark of dilated cardiomyopathy; however, its etiology is not well understood. Cardiac-specific deletion of the transcriptional coactivator mediator subunit 1 (Med1) results in dilated cardiomyopathy, decreased cardiac function, and lethality. Med1 deletion disrupted cardiac mitochondrial and metabolic gene expression patterns.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  cardiovascular disease; mediator complex; metabolism; transcription

Mesh:

Substances:

Year:  2017        PMID: 28159809      PMCID: PMC5407164          DOI: 10.1152/ajpheart.00728.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  38 in total

Review 1.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

Review 2.  Muscle as a "mediator" of systemic metabolism.

Authors:  Kedryn K Baskin; Benjamin R Winders; Eric N Olson
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

3.  Novel critical role of a human Mediator complex for basal RNA polymerase II transcription.

Authors:  G Mittler; E Kremmer; H T Timmers; M Meisterernst
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

4.  An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria.

Authors:  M A Birch-Machin; H L Briggs; A A Saborido; L A Bindoff; D M Turnbull
Journal:  Biochem Med Metab Biol       Date:  1994-02

5.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 6.  The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation.

Authors:  Sohail Malik; Robert G Roeder
Journal:  Nat Rev Genet       Date:  2010-10-13       Impact factor: 53.242

7.  Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats.

Authors:  A Barrientos; C Marín; O Miró; J Casademont; M Gómez; V Nunes; E Tolosa; A Urbano-Márquez; F Cardellach
Journal:  J Neurosci Res       Date:  1998-08-15       Impact factor: 4.164

8.  Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.

Authors:  Yuzhi Jia; Navin Viswakarma; Tao Fu; Songtao Yu; M Sambasiva Rao; Jayme Borensztajn; Janardan K Reddy
Journal:  Gene Expr       Date:  2009

9.  The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload.

Authors:  Janice M Huss; Ken-ichi Imahashi; Catherine R Dufour; Carla J Weinheimer; Michael Courtois; Atilla Kovacs; Vincent Giguère; Elizabeth Murphy; Daniel P Kelly
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

Review 10.  Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.

Authors:  Colleen M Dewey; Kathryn M Spitler; Jessica M Ponce; Duane D Hall; Chad E Grueter
Journal:  J Am Heart Assoc       Date:  2016-05-31       Impact factor: 5.501

View more
  16 in total

1.  Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling.

Authors:  Duane D Hall; Kathryn M Spitler; Chad E Grueter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-21       Impact factor: 4.733

2.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

3.  Regulation of cardiac transcription by thyroid hormone and Med13.

Authors:  Rachel A Minerath; Colleen M Dewey; Duane D Hall; Chad E Grueter
Journal:  J Mol Cell Cardiol       Date:  2019-02-12       Impact factor: 5.000

Review 4.  Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure.

Authors:  Rachel A Minerath; Duane D Hall; Chad E Grueter
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

Review 5.  Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification.

Authors:  Hui Tao; Zheng-Yu Song; Xuan-Sheng Ding; Jing-Jing Yang; Kai-Hu Shi; Jun Li
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

6.  MED12 regulates a transcriptional network of calcium-handling genes in the heart.

Authors:  Kedryn K Baskin; Catherine A Makarewich; Susan M DeLeon; Wenduo Ye; Beibei Chen; Nadine Beetz; Heinrich Schrewe; Rhonda Bassel-Duby; Eric N Olson
Journal:  JCI Insight       Date:  2017-07-20

7.  Mitochondria Associated MicroRNA Expression Profiling of Heart Failure.

Authors:  Xiaoxia Wang; Chun Song; Xiao Zhou; Xiaorui Han; Jun Li; Zengwu Wang; Haibao Shang; Yuli Liu; Huiqing Cao
Journal:  Biomed Res Int       Date:  2017-09-24       Impact factor: 3.411

8.  Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure.

Authors:  Duane D Hall; Jessica M Ponce; Biyi Chen; Kathryn M Spitler; Adrianne Alexia; Gavin Y Oudit; Long-Sheng Song; Chad E Grueter
Journal:  JCI Insight       Date:  2017-08-03

9.  PIMT/NCOA6IP Deletion in the Mouse Heart Causes Delayed Cardiomyopathy Attributable to Perturbation in Energy Metabolism.

Authors:  Yuzhi Jia; Ning Liu; Navin Viswakarma; Ruya Sun; Mathew J Schipma; Meng Shang; Edward B Thorp; Yashpal S Kanwar; Bayar Thimmapaya; Janardan K Reddy
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

10.  MicroRNA-146a protects against myocardial ischaemia reperfusion injury by targeting Med1.

Authors:  Tiantian Zhang; Yiwen Ma; Lin Gao; Chengyu Mao; Huasu Zeng; Xiaofei Wang; Yapin Sun; Jianmin Gu; Yue Wang; Kan Chen; Zhihua Han; Yuqi Fan; Jun Gu; Junfeng Zhang; Changqian Wang
Journal:  Cell Mol Biol Lett       Date:  2019-11-27       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.